Key result
Oral pretreatment with a 0.035% luteolin diet significantly protected against angiotensin II-induced cardiac fibrosis and hypertrophy in rats.
Why the study?
Does luteolin pretreatment prevent cardiac remodeling in Ang II-infused rats?
Does luteolin pretreatment prevent cardiac remodeling in Ang II-infused rats?
p-value: p=0.002
Luteolin, a food-derived flavonoid, attenuates Angiotensin II-induced cardiac remodeling and oxidative stress in a rat model, suggesting potential protective cardiovascular effects.
Luteolin shows no immediate clinical role; leaves open translation of flavonoid protection to human hypertensive remodeling.
Oxidative stress has been implicated in cardiac remodeling (cardiac fibrosis and hypertrophy), which impairs cardiac function and metabolism; therefore, it is anticipated antioxidative compounds will have protective properties against cardiac remodeling. Luteolin (3',4',5,7-tetrahydroxyflavone), a widely distributed flavonoid found in many herbal extracts including celery, green pepper, perilla leaves and seeds, and chamomile, is a known to be a potent antioxidant and was previously demonstrated to exert an antifibrotic effect in the lungs and the liver. In this study, we clearly demonstrate that oral pretreatment with the higher-luteolin diet (0.035% (wt/wt)) protected against cardiac fibrosis and hypertrophy as well as a hyperoxidative state in Ang II-infused rats. In cardiac tissue, increased gene expression levels of TGFβ1, CTGF, Nox2, Nox4, ANP, and BNP induced by Ang II were restored by oral pretreatment of this high-luteolin diet. In cultured rat cardiac fibroblasts, H2O2-induced TGFβ1 expression and the phosphorylation of JNK were suppressed by luteolin pretreatment. In conclusion, food-derived luteolin has protective actions against Ang II-induced cardiac remodeling, which could be mediated through attenuation of oxidative stress.
No takes yet. Share an insight, caveat, or question.
Nakayama et al. (2015) studied Angiotensin II-induced cardiac remodeling. Luteolin vs. Angiotensin II alone was evaluated on Left ventricular weight (p=0.002). Oral pretreatment with a 0.035% luteolin diet significantly protected against angiotensin II-induced cardiac fibrosis and hypertrophy in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: